Type I Collagen Fragments in the GCF and Saliva During OTM
Launched by ALEXANDRIA UNIVERSITY · Aug 22, 2021
Trial Information
Current as of May 22, 2025
Unknown status
Keywords
ClinConnect Summary
Type I Collagen fragments ICTP (cross-linked carboxyterminal telopeptide of type 1 collagen) and CTX (C-terminal cross-linked telopeptide of type I collagen) are specific bone resorption biomarkers released in the circulation after osteoclastic bone resorption and collagen degradation and were found to be released in gingival crevicular fluid (GCF) and saliva during metabolic bone diseases and active periodontitis. So the aim of the study is to investigate the levels of ICTP and CTX in GCF and saliva during initial leveling and alignment of the teeth in a sample of adolescents undergoing or...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The age ranges from 13-18 years old.
- • Good oral hygiene.
- • Clinical gingival health on the intact periodontium.
- • Permanent dentition.
- • Moderate crowding.
- • Non-extraction treatment plan. If extraction of teeth is required, the treatment plan should allow for postponing extraction after sample collection.
- Exclusion Criteria:
- • Systemic diseases associated with loss of periodontal supporting tissues.
- • Metabolic bone diseases and systemic medications affecting bone metabolism.
- • Craniofacial anomalies such as cleft lip and/or palate.
- • Xerostomia.
- • Tobacco-related habits such as smoking, tobacco chewing, etc.
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Trial Officials
Omar Tareq
Principal Investigator
Principal Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials